Calumet Specialty Products Partners (NASDAQ:CLMT) Rating Increased to Sell at StockNews.com

StockNews.com upgraded shares of Calumet Specialty Products Partners (NASDAQ:CLMT – Free Report) to a sell rating in a research report report published on Monday. A number of other brokerages have also weighed in on CLMT. TD Cowen dropped their target price on shares of Calumet Specialty Products Partners from $27.00 to $26.00 and set a […]

Leave a Reply

Your email address will not be published.

Previous post Pure Cycle (NASDAQ:PCYO) Upgraded at StockNews.com
Next post Rocket Pharmaceuticals (NASDAQ:RCKT) Earns “Buy” Rating from Chardan Capital